phrykt

Shattuck Labs, Inc. (STTK): who owns it and who trades it

As of Nov 16, 2026, STTK insiders reported 6 open-market sales worth $592K and 1 purchase worth $250K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Arundathy N. Pandite (Chief Medical Officer), with $409K. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Shattuck Labs

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Funds and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns STTK

100 funds and institutions reported STTK shares worth $583M at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is T. Rowe Price Investment Management, Inc. with 17.5%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

T. Rowe Price Investment Management, Inc.17.5%
Adage Capital Partners Gp, L.l.c.10.6%
Redmile Group, LLC9.0%
Orbimed Advisors LLC8.2%
Prosight Management, LP7.8%
BlackRock, Inc.5.1%
Frazier Life Sciences Management, L.P.4.9%
NEXTBio Capital Management LP4.9%
Deep Track Capital, LP4.8%
Vanguard Capital Management LLC4.2%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
T. Rowe Price Investment Management, Inc.13.43M17.52%$93.2M+36%
Adage Capital Partners Gp, L.l.c.8.12M10.59%$56.4M+75%
Redmile Group, LLC6.89M8.99%$47.8M+24%
Orbimed Advisors LLC6.31M8.22%$43.8MNo change
Prosight Management, LP5.96M7.77%$41.3M+19%
BlackRock, Inc.3.94M5.13%$27.3M+671%
Frazier Life Sciences Management, L.P.3.75M4.89%$26MNew
NEXTBio Capital Management LP3.73M4.86%$25.9M+18%
Deep Track Capital, LP3.71M4.83%$25.7MNew
Vanguard Capital Management LLC3.21M4.18%$22.3M+41%
T. Rowe Price Associates2.64M3.44%$18.3M+48%
Pinnacle Associates Ltd1.87M2.44%$13M+37%
Wellington Management Group LLP1.77M2.31%$12.3MNew
Geode Capital Management, LLC1.58M2.07%$11M+145%
Clark Estates Inc1.43M1.87%$9.9M-3%
Aberdeen Group plc1.41M1.83%$9.8M+21%
Point72 Asset Management, L.P.1.17M1.53%$8.1M+14%
683 Capital Management, LLC1.16M1.51%$8M+45%
State Street Corp1.03M1.34%$7.1M+289%
Boxer Capital Management, LLC1.00M1.30%$6.9MNew

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, STTK insiders reported $250K of open-market purchases and $592K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$250K
1 trades, 1 people
Sales, 12 months
$592K
6 trades, 2 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Jul 2, 2026
Filed Jul 7, 2026

Purchases and sales by month

$376K$376KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Jul 2, 2026Abhinav A. ShuklaChief Technical OfficerSale410$7.01$2.9KForm 4
Jul 1, 2026Abhinav A. ShuklaChief Technical OfficerSale100$7.07$707Form 4
Jun 30, 2026Abhinav A. ShuklaChief Technical OfficerSale23,365$7.08$165KForm 4
Jun 30, 2026Arundathy N. PanditeChief Medical OfficerSale30,000$7.01$210KForm 4
Jun 9, 2026Clay B SiegallDirectorPurchase62,500$4.00$250KForm 4
May 12, 2026Abhinav A. ShuklaChief Technical OfficerSale2,032$7.01$14.2KForm 4
May 12, 2026Arundathy N. PanditeChief Medical OfficerSale30,000$6.61$198KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Arundathy N. PanditeChief Medical Officer–$409KJun 30, 2026
Clay B SiegallDirector$250K–Jun 9, 2026
Abhinav A. ShuklaChief Technical Officer–$183KJul 2, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

STTK short interest

High short interest. 10.7% of STTK shares are sold short: about 1 share in 9. Over the last 12 reports the number of shares short went up 714%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 10.75M STTK shares were sold short, 10.7% of the shares outstanding, up 2.9% from the report before. At the average daily volume of 898,075 shares, buying them all back would take about 12.0 trading days (days to cover).

Shares short, % of all shares

10.7%May 15Oct 3012.3%

Days to cover

12.0May 15Oct 3013.5

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202610.75M10.71%+3%898,07512.0
Oct 15, 202610.44M10.40%-5%1.44M7.2
Sep 30, 202610.95M10.91%+61%1.82M6.0
Sep 15, 20266.81M6.78%+22%812,7368.4
Aug 31, 20265.57M5.55%-7%733,9457.6
Aug 14, 20266.01M5.98%-6%1.03M5.8
Jul 31, 20266.39M8.34%-18%1.21M5.3
Jul 15, 20267.80M10.18%+32%1.34M5.8
Jun 30, 20265.93M7.73%+134%2.25M2.6
Jun 15, 20262.54M3.31%+121%1.40M1.8
May 29, 20261.15M1.50%-13%549,1042.1
May 15, 20261.32M1.72%-7%612,7542.1

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Shattuck Labs company events

Shattuck Labs filed 9 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 5, 2026.

  1. Nov 5, 2026ResultsReleased financial results. Filing
  2. Aug 11, 2026ResultsReleased financial results. Filing
  3. Jun 11, 2026AgreementShattuck Labs, Inc. entered into an underwriting agreement with Leerink Partners LLC, J.P. Morgan Securities LLC, Piper Sandler & Co. and Cantor Fitzgerald & Co., as the representatives of the underwriters named therein, relating to the offering, issuance and sale of 10,879,376 shares of the… Filing
  4. Jun 9, 2026AnnouncementThe Company released its presentation on data from its Phase 1 clinical trial of SL-325. Filing
  5. Jun 2, 2026LeadershipDeparture of Director or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Filing
  6. May 7, 2026ResultsReleased financial results. Filing
  7. Mar 5, 2026ResultsReleased financial results. Filing
  8. Feb 5, 2026AnnouncementThe Board of Directors of Shattuck Labs, Inc. determined that the 2026 annual meeting of stockholders will be held on Thursday, May 28, 2026. Filing
  9. Jan 22, 2026AgreementShattuck Labs, Inc. entered into a sales agreement with Leerink Partners LLC, pursuant to which the Company may offer and sell from time to time shares of the Company’s common stock, $0.0001 par value per share, through the Agent. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Shattuck Labs financials

Famous investors that hold STTK

5 of the 50 well-known investors we track reported holding STTK in their latest 13F filing. The largest position is Ken Griffin's, worth $11.7M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 20261.72M$11.7M0.0%New
Steve Cohen · Point72 Asset ManagementQ3 20261.33M$9.1M0.0%+13%
Jim Simons · Renaissance TechnologiesQ3 2026286,607$2M0.0%-61%
Israel Englander · Millennium ManagementQ3 2026127,117$867K0.0%-34%
Ken Fisher · Fisher Asset ManagementQ3 202684,306$575K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named STTK in the last 120 days.

FiledHolderFormStake
Nov 16, 2026Deep Track Capital, LP13G/A4.9%
Nov 16, 2026Deep Track Capital, LP13G/A4.9%
Nov 16, 2026T. Rowe Price Investment Management, Inc.13G/A14.3%
Nov 16, 2026T. Rowe Price Investment Management, Inc.13G/A14.3%
Oct 27, 2026BlackRock, Inc.13G5.3%
Oct 27, 2026BlackRock, Inc.13G5.3%

Questions about Shattuck Labs, Inc. (STTK) stock

Who owns the most STTK stock?

The largest reported owner of Shattuck Labs, Inc. (STTK) is T. Rowe Price Investment Management, Inc., with 17.5% of the company. In total, 100 funds and institutions reported holding STTK at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are STTK insiders buying or selling?

In the last 12 months, STTK insiders reported 1 open-market purchase worth $250K and 6 sales worth $592K. The latest trade was on Jul 2, 2026. See every trade.

What is the short interest in STTK?

As of Oct 30, 2026, 10.75M STTK shares were sold short, 10.7% of the shares outstanding, up 2.9% from the report before. At the average daily volume of 898,075 shares, buying them all back would take about 12.0 trading days (days to cover). See the history.

Which famous investors hold STTK?

5 of the 50 well-known investors we track reported STTK in their latest 13F filing, including Ken Griffin, Steve Cohen, Jim Simons. The largest position is worth $11.7M. See all holders.

Executive pay

Shattuck Labs's chief executive was paid a total of $1.5M for the year ended Dec 31, 2025, down 52% from $3.2M the year before. In the last 12 months, Shattuck Labs's executives and directors bought $250K of stock on the open market and sold $592K.

Chief executive, total pay$1.5MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$3.4MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$908KThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.